A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein.
Laron syndrome (LS) is a severe autosomal recessive form of GH resistance resulting from molecular defects in the GH receptor (GHR). Affected individuals have extreme short stature and a typical facial phenotype. The point mutations in the GHR gene identified in this condition have until now been confined to the region encoding the extracellular domain of the receptor. We report here the first homozygous point mutation within the intracellular domain of the GHR in two LS cousins distinguishable from classical LS patients only by the presence of elevated GH-binding protein (GHBP) in their serum. A G to C transversion at the vital - 1 position in the splice donor site of exon 8 disrupts normal splicing, resulting in the complete skipping of exon 8, producing a mutant GHR protein lacking transmembrane and intracellular domains. We predict that this mutant protein would not be anchored in the cell membrane and would be measurable in the circulation as GHBP, hence explaining the phenotype of severe GH resistance combined with elevated circulating GHBP.
Woods
K A
KA
Department of Endocrinology, St. Bartholomew's Hospital, London, United Kingdom.
Fraser
N C
NC
Postel-Vinay
M C
MC
Savage
M O
MO
Clark
A J
AJ
D001483:Base Sequence; D002352:Carrier Proteins / Q000097:blood*; D018076:DNA, Complementary / Q000032:analysis; D004351:Drug Resistance / Q000235:genetics*; D005091:Exons; D006130:Growth Disorders / Q000097:blood / Q000235:genetics*; D006720:Homozygote; D006801:Humans; D008969:Molecular Sequence Data; D010375:Pedigree; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D012326:RNA Splicing / Q000235:genetics*; D011986:Receptors, Somatotropin / Q000235:genetics*; D013577:Syndrome
D002352:Carrier Proteins; D018076:DNA, Complementary; D011986:Receptors, Somatotropin; C051815:somatotropin-binding protein